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Huda Zoghbi is the Ralph D. Feigin Distinguished Professor of Molecular Human Genetics, Neuroscience, Pediatrics, and Neurology and an Investigator with the Howard Hughes Medical Institute at Baylor College of Medicine. She is also the Director of the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital. During her Pediatric and Neurology residencies at Texas Children's Hospital, she grew frustrated with the lack of options neurologists could offer patients, so she decided to pursue postdoctoral research training in molecular biology and genetics with Arthur L. Beaudet at Baylor. She began her independent lab studying the adult-onset neurodegenerative disease spinocerebellar ataxia type 1 and branched out to study other neurodegenerative conditions. Her lab also studies postnatal neurodevelopmental disorders, most notably Rett syndrome, and through studying neurodevelopment in the mammalian embryo she has made discoveries relevant to disorders ranging from deafness to cancer and respiratory disorders that afflict newborns. Her current work uses genetics and neuronal network studies in animal models to gain deeper understanding of the mechanisms driving Rett and MECP2 duplication syndromes as well as certain neurodegenerative disorders in the hope of finding viable therapies.
What do you think are the big questions to be answered next in your field? Thinking about both childhood and adult disorders, one big question is: what are the molecular and environmental factors that contribute to neuronal vulnerabilities? If we knew the answer to this question, we might be able to find some paths for neuroprotection. There has been an alarming rise in the incidence of childhood neurological disorders such as autism spectrum disorders and intellectual disabilities. Why is the incidence so high? While genetic abnormalities underlie many of these disorders, the fact that many of the genetic lesions are de novo raises the question of whether environmental factors increase the risk for de novo genomic rearrangements and mutations or could cause the consequences of these mutations to be more severe. Similarly, we know that advancing age increases the risk for numerous neurodegenerative conditions, but clearly not everyone succumbs. Understanding the interplay between environmental and genetic factors is critical, because we should be able to more easily modify the former. Moving beyond genes to brain cells and networks, why is the rise biased for disorders that affect cognition, language, and social behavior? Why don't we see a similar increase in motor or sensory disorders? Perhaps neurons and circuits that mediate cognition, language, and social behavior are most vulnerable, or disruptions in any node within such circuits totally disrupt such functions.
Which aspects of science in your field or in general would you wish the general public knew more about? It is our duty as scientists to communicate to the public the value of science in our daily lives, explain the meaning or implications of a particular scientific discovery, and be clear about the challenges of translating fundamental discoveries to practical solutions. Unfortunately, in an era where communication is frequently limited to sound bites that are often exaggerated to sell magazines or attract viewers, the public hears of discovery after discovery without experiencing a tangible benefit. What I wish the general public knew is that the reason things don't translate quickly is because there are many steps between a scientific discovery and the development of diseasemodifying therapies. Failures often result from the pressure to accelerate ''translation'' when the basic language of a particular disease is not well understood. The investment to enhance our fundamental knowledge of disease mechanisms will save resources for more timely clinical trials that are built on a stronger foundation.
To tackle your favorite research question, is there a tool that needs to be developed, or is one currently available that could be implemented in a novel way? I wish I had access to two types of tools: one molecular and the other neurobiological. At the molecular level, I am frustrated by the lack of concerted efforts to understand the functional significance of variants and modifications of all possible isoforms of proteins encoded by our genome (and many RNAs, for that matter). Without such data, we are hampered in understanding what variations might cause or increase the risk of a particular neuronal vulnerability or disorder. We are also missing the opportunity to understand functional relationships between various gene products and leaving so much sequencing data untapped. To generate such data will take major cross-species efforts and better human phenotyping of every sequenced individual. It is time to move beyond sequence to function so that we can capitalize on the sequencing data at hand and begin to identify potential pathways for intervention. At the neurobiological level, I wish we had a tool that can safely interrogate the human brain at very high resolution. We need to study human beings to understand what brain networks mediate certain neuropsychiatric behaviors and phenotypes. Understanding neurological and behavioral functions (or dysfunctions) at a network level with a high resolution that reveals input and output tracts and that can identify specific functions and behaviors will provide the foundation for future neuromodulatory approaches.
What has been the highlight of your career? The highlight of my career has been my trainees. They make my career a joy. They share my passion for the work we do, they work tirelessly to solve problems that intrigue us, they have made the discoveries I am most proud of, and they are committed to continuing the journey to find ways to help society through research. By myself I can only accomplish so much, but great trainees can multiply that effect a hundred times over within one generation and even more in future generations. Beyond the work and the joy of sharing with them a career in science, they all become part of my family, and I cherish my relationship with them. I am deeply honored they call themselves ''Zoghbians,'' and I am so privileged to have them in my life!
What is your view on big data and gathering collaborations as opposed to hypothesis-driven research by small groups? My view is that there is no opposition! We need both. Hypothesis-driven research will always surprise and delight us by the unexpected discoveries it reveals, the impact of which might only be apparent decades later. We have to support it and preserve it. We understand that an artist or musician does not produce great work because they're told to solve a particular problem; they create great works because they pursue an idea they find interesting and see where it leads. We must understand that scientific discovery also comes from letting people pursue ideas. That said, there are many problems in science that are best solved by a team (typically interdisciplinary teams-see next question). The value of such efforts is great (take the sequencing of the genome or the Allen Brain Atlas as examples). In this same category I would place scientists who sacrifice a great deal of their time and effort to create resources that can be used by the entire community; this kind of work is often not rewarded, but it needs to be. Big collaborative efforts accommodate scientists who like to work in teams, those who are happy to produce data that will inspire others to generate hypotheses, those who are happy to share credit, and those who are motivated by solving big problems rather than answering focused questions. Society and the scientific community need both types of efforts. Of course big data suffer from being difficult to access, reproduce, or interpret. They might not always have the precision and quality of data generated and scrutinized by a small group, but as the tools to analyze big data continue to improve and be shared, laboratories big and small will benefit tremendously from big data resources. How do you view the level of crosstalk between disciplines, for example physics, math, engineering, humanities, and social science? More crosstalk is sorely needed in order for biomedical research to have the greatest benefit for society. We need the input of mathematicians to help us make better use of billions of pieces of data that are dispersed on various sites or still buried in labs. We can only consider models to interpret how certain networks might work if we have theoretical physicists listening to the challenges we face after we generate neuronal activity data. Interactions with the humanities and social sciences are crucial for scientists to consider the implications of their work on individuals and society.
What is your favorite experiment? My favorite experiment was the one designing 10 oligonucleotides to capture all 64 possible trinucleotide repeat configurations in the genome to test the hypothesis that spinocerebellar ataxia type 1 (SCA1) is caused by a triplet repeat expansion. I heard Dr. Thomas Caskey, then chair of genetics at my institution, announce his discovery that myotonic dystrophy is caused by a triplet repeat expansion, which explained the phenomenon of anticipation (earlier and more severe onset of disease in successive generations) because the triplet repeat tract keeps expanding with each transmission. Having seen anticipation in the Texas SCA1 family I was studying, my collaborator Harry Orr (at University of Minnesota) and I immediately embarked on a search for such an expansion in our respective SCA1 patients. We divided the candidate SCA1 region (1 million base pairs) between the two of us, making sure that there is a 75 kb region of overlap. We both discovered the CAG repeat expansion in ATAXIN-1 on the same day, April 8, 1993, and it was in that 75 kb region. I like the experiment because it was elegant to use the oligonucleotides to interrogate all repeats, it was efficient in that it obviated sequencing every candidate gene in the 1Mb region, and it was an amazing reward for our collaboration.
What motivated you to become a scientist? My patients. Training as a child neurologist in the early 1980s drove home the depressing state of the field. We could diagnose but not treat. This reality and my encounter with Rett syndrome patients inspired me to pursue molecular biology and genetics training. I found it both heart-wrenching and intriguing that girls with Rett syndrome start life with a normal developmental course, then all that stops, followed by regression without degeneration. I haven't found a treatment for Rett yet, but I have hope of helping the patients I care so deeply about.
What are the biggest problems/ challenges science as a whole is facing today? There are several problems, and it is going to take the whole community-the scientists, the funders, institutions, and journals. Here are two we need to deal with. (1) Public image: We have to do a better job communicating the value of science to society and inspire young students about the reward of careers in science. Scientists must bear the biggest responsibilities here, because we are the face of science and we are the ones who must manage expectations. We should not hype our data, but rather educate about its value in the context of advancing knowledge or charting a new path forward. We need to explain why we love what we do. We must share with young students the thrill of not knowing what the day will bring in the lab, and the intense reward of knowing that what you are doing will one day help someone. (2) Resources: Resources are too limited. The scarce resources for research funding, the incredible pressure to publish, and the sense that there are too few jobs for too many good applicants create an environment in which people are hasty, anxious, and likely to make mistakes. It also leads some to abandon a career in science. Journals are also responsible, because their disinterest in publishing negative results causes other scientists to waste time and effort trying to follow up on data that are not robust.
What advice do you find yourself giving to your students and postdocs? Focus, be observant, and keep up with the literature. You can only make a discovery if you focus on a problem and dig deep. Being observant and attentive to every detail is key. Many of the discoveries we made came about from attending to a side observation that we were not looking for. Noting and following up on tiny specks of blue near the ear and in the intestine of mouse embryos carrying a Math1-LacZ allele led us to discover the role of atonal homolog 1 in inner ear hair cell development and secretory cells of the intestine. I emphasize scholarship. You have to know what others have done to ask meaningful questions and advance the field. I urge postdocs becoming faculty to work as long as they can at the bench in their new labs. They are going to have the best hands, and working side by side with trainees is one of the most fun experiences when building a career. I advise them not to travel and not to sit in front of the computer (unless they are computational biologists). I did not have an office my first few years as faculty, simply a desk by my bench. I am convinced this contributed to my productivity.
What do you do when you are not in the lab? There are many things I enjoy doing. I enjoy exercise and long walks. I love cooking-it's relaxing, gives me a chance to be creative, and provides a wonderful way to gather around a table with family and friends. Beyond these routines, I enjoy the opera and reading literature.
Did you encounter particular difficulties? How did you overcome them? The first difficulty was the eruption of the civil war in Lebanon during my medical school training. I came to the U.S. after completing my first year at the American University of Beirut, but the escalation of the war kept me here and forced me to transfer and adjust to a new life. The transition was tough, given that my parents and friends back home were in mortal danger. I coped by studying and working hard. It was my distraction.
The biggest scientific difficulty I faced was pursuing the genetic basis of Rett syndrome (a sporadic disorder) when the tools were not there yet. The challenge was not only technical but psychological, in that I had to deal with skeptics who kept insisting that a gene could not underlie a sporadic disorder. What kept me going was a strong intuition that only a gene could explain the reproducible and almost consistent clinical picture of Rett syndrome.
What career paths did you consider other than a scientist? The first path I contemplated was a career in writing and a major in English literature. Upon my mother's insistence, I abandoned this idea and went to medical school. Then I was planning to be a pediatric cardiologist until I became fascinated by neurology. Then I thought I would be an academic child neurologist until I met children with devastating neurological disorders and realized my limitations as a clinician and the need to pursue research to help my patients. In science I finally found my calling, and I am sticking with it!
